MENLO PARK, Calif., Feb. 20 /PRNewswire/ -- 5AM Ventures, specializing in seed and early-stage investments in next-generation life science companies, today announced the expansion of the firm’s investment team with the appointment of Richard Ulevitch, PhD, as Venture Partner. 5AM Ventures also announced the promotion of two of the firm’s senior associates, Kevin M. Forrest, PhD, and R. Andrew McMillan, PhD, to Principal. Drs. Forrest and McMillan have been with the 5AM team since early 2005. Carin M. Rollins, a founder and formerly a Principal has transitioned to a consulting role with the firm.
